Central Nervous System-Endogenous TLR7 and TLR9 Induce Different Immune Responses and Effects on Experimental Autoimmune Encephalomyelitis
Innate receptors, including Toll like receptors (TLRs), are implicated in pathogenesis of CNS inflammatory diseases such as multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). TLR response to pathogens or endogenous signals includes production of immunoregul...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2021-06-01
|
| Series: | Frontiers in Neuroscience |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2021.685645/full |
| _version_ | 1819103222510387200 |
|---|---|
| author | Ruthe Storgaard Dieu Vian Wais Michael Zaucha Sørensen Joanna Marczynska Magdalena Dubik Stephanie Kavan Mads Thomassen Mark Burton Torben Kruse Reza Khorooshi Trevor Owens |
| author_facet | Ruthe Storgaard Dieu Vian Wais Michael Zaucha Sørensen Joanna Marczynska Magdalena Dubik Stephanie Kavan Mads Thomassen Mark Burton Torben Kruse Reza Khorooshi Trevor Owens |
| author_sort | Ruthe Storgaard Dieu |
| collection | DOAJ |
| description | Innate receptors, including Toll like receptors (TLRs), are implicated in pathogenesis of CNS inflammatory diseases such as multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). TLR response to pathogens or endogenous signals includes production of immunoregulatory mediators. One of these, interferon (IFN)β, a Type I IFN, plays a protective role in MS and EAE. We have previously shown that intrathecal administration of selected TLR ligands induced IFNβ and infiltration of blood-derived myeloid cells into the central nervous system (CNS), and suppressed EAE in mice. We have now extended these studies to evaluate a potential therapeutic role for CNS-endogenous TLR7 and TLR9. Intrathecal application of Imiquimod (TLR7 ligand) or CpG oligonucleotide (TLR9 ligand) into CNS of otherwise unmanipulated mice induced IFNβ expression, with greater magnitude in response to CpG. CD45+ cells in the meninges were identified as source of IFNβ. Intrathecal CpG induced infiltration of monocytes, neutrophils, CD4+ T cells and NK cells whereas Imiquimod did not recruit blood-derived CD45+ cells. CpG, but not Imiquimod, had a beneficial effect on EAE, when given at time of disease onset. This therapeutic effect of CpG on EAE was not seen in mice lacking the Type I IFN receptor. In mice with EAE treated with CpG, the proportion of monocytes was significantly increased in the CNS. Infiltrating cells were predominantly localized to spinal cord meninges and demyelination was significantly reduced compared to non-treated mice with EAE. Our findings show that TLR7 and TLR9 signaling induce distinct inflammatory responses in the CNS with different outcome in EAE and point to recruitment of blood-derived cells and IFNβ induction as possible mechanistic links between TLR9 stimulation and amelioration of EAE. The protective role of TLR9 signaling in the CNS may have application in treatment of diseases such as MS. |
| first_indexed | 2024-12-22T01:47:02Z |
| format | Article |
| id | doaj.art-b64a2d79216d4c6dbb396a2f748f9b86 |
| institution | Directory Open Access Journal |
| issn | 1662-453X |
| language | English |
| last_indexed | 2024-12-22T01:47:02Z |
| publishDate | 2021-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Neuroscience |
| spelling | doaj.art-b64a2d79216d4c6dbb396a2f748f9b862022-12-21T18:43:01ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2021-06-011510.3389/fnins.2021.685645685645Central Nervous System-Endogenous TLR7 and TLR9 Induce Different Immune Responses and Effects on Experimental Autoimmune EncephalomyelitisRuthe Storgaard Dieu0Vian Wais1Michael Zaucha Sørensen2Joanna Marczynska3Magdalena Dubik4Stephanie Kavan5Mads Thomassen6Mark Burton7Torben Kruse8Reza Khorooshi9Trevor Owens10Department of Neurobiology Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, DenmarkDepartment of Neurobiology Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, DenmarkDepartment of Neurobiology Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, DenmarkDepartment of Neurobiology Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, DenmarkDepartment of Neurobiology Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, DenmarkDepartment of Clinical Genetics, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark, Odense, DenmarkDepartment of Clinical Genetics, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark, Odense, DenmarkDepartment of Clinical Genetics, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark, Odense, DenmarkDepartment of Clinical Genetics, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark, Odense, DenmarkDepartment of Neurobiology Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, DenmarkDepartment of Neurobiology Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, DenmarkInnate receptors, including Toll like receptors (TLRs), are implicated in pathogenesis of CNS inflammatory diseases such as multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). TLR response to pathogens or endogenous signals includes production of immunoregulatory mediators. One of these, interferon (IFN)β, a Type I IFN, plays a protective role in MS and EAE. We have previously shown that intrathecal administration of selected TLR ligands induced IFNβ and infiltration of blood-derived myeloid cells into the central nervous system (CNS), and suppressed EAE in mice. We have now extended these studies to evaluate a potential therapeutic role for CNS-endogenous TLR7 and TLR9. Intrathecal application of Imiquimod (TLR7 ligand) or CpG oligonucleotide (TLR9 ligand) into CNS of otherwise unmanipulated mice induced IFNβ expression, with greater magnitude in response to CpG. CD45+ cells in the meninges were identified as source of IFNβ. Intrathecal CpG induced infiltration of monocytes, neutrophils, CD4+ T cells and NK cells whereas Imiquimod did not recruit blood-derived CD45+ cells. CpG, but not Imiquimod, had a beneficial effect on EAE, when given at time of disease onset. This therapeutic effect of CpG on EAE was not seen in mice lacking the Type I IFN receptor. In mice with EAE treated with CpG, the proportion of monocytes was significantly increased in the CNS. Infiltrating cells were predominantly localized to spinal cord meninges and demyelination was significantly reduced compared to non-treated mice with EAE. Our findings show that TLR7 and TLR9 signaling induce distinct inflammatory responses in the CNS with different outcome in EAE and point to recruitment of blood-derived cells and IFNβ induction as possible mechanistic links between TLR9 stimulation and amelioration of EAE. The protective role of TLR9 signaling in the CNS may have application in treatment of diseases such as MS.https://www.frontiersin.org/articles/10.3389/fnins.2021.685645/fulltoll-like receptorinnate signalingexperimental autoimmune encephalomyelitismonocytesType I interferons |
| spellingShingle | Ruthe Storgaard Dieu Vian Wais Michael Zaucha Sørensen Joanna Marczynska Magdalena Dubik Stephanie Kavan Mads Thomassen Mark Burton Torben Kruse Reza Khorooshi Trevor Owens Central Nervous System-Endogenous TLR7 and TLR9 Induce Different Immune Responses and Effects on Experimental Autoimmune Encephalomyelitis Frontiers in Neuroscience toll-like receptor innate signaling experimental autoimmune encephalomyelitis monocytes Type I interferons |
| title | Central Nervous System-Endogenous TLR7 and TLR9 Induce Different Immune Responses and Effects on Experimental Autoimmune Encephalomyelitis |
| title_full | Central Nervous System-Endogenous TLR7 and TLR9 Induce Different Immune Responses and Effects on Experimental Autoimmune Encephalomyelitis |
| title_fullStr | Central Nervous System-Endogenous TLR7 and TLR9 Induce Different Immune Responses and Effects on Experimental Autoimmune Encephalomyelitis |
| title_full_unstemmed | Central Nervous System-Endogenous TLR7 and TLR9 Induce Different Immune Responses and Effects on Experimental Autoimmune Encephalomyelitis |
| title_short | Central Nervous System-Endogenous TLR7 and TLR9 Induce Different Immune Responses and Effects on Experimental Autoimmune Encephalomyelitis |
| title_sort | central nervous system endogenous tlr7 and tlr9 induce different immune responses and effects on experimental autoimmune encephalomyelitis |
| topic | toll-like receptor innate signaling experimental autoimmune encephalomyelitis monocytes Type I interferons |
| url | https://www.frontiersin.org/articles/10.3389/fnins.2021.685645/full |
| work_keys_str_mv | AT ruthestorgaarddieu centralnervoussystemendogenoustlr7andtlr9inducedifferentimmuneresponsesandeffectsonexperimentalautoimmuneencephalomyelitis AT vianwais centralnervoussystemendogenoustlr7andtlr9inducedifferentimmuneresponsesandeffectsonexperimentalautoimmuneencephalomyelitis AT michaelzauchasørensen centralnervoussystemendogenoustlr7andtlr9inducedifferentimmuneresponsesandeffectsonexperimentalautoimmuneencephalomyelitis AT joannamarczynska centralnervoussystemendogenoustlr7andtlr9inducedifferentimmuneresponsesandeffectsonexperimentalautoimmuneencephalomyelitis AT magdalenadubik centralnervoussystemendogenoustlr7andtlr9inducedifferentimmuneresponsesandeffectsonexperimentalautoimmuneencephalomyelitis AT stephaniekavan centralnervoussystemendogenoustlr7andtlr9inducedifferentimmuneresponsesandeffectsonexperimentalautoimmuneencephalomyelitis AT madsthomassen centralnervoussystemendogenoustlr7andtlr9inducedifferentimmuneresponsesandeffectsonexperimentalautoimmuneencephalomyelitis AT markburton centralnervoussystemendogenoustlr7andtlr9inducedifferentimmuneresponsesandeffectsonexperimentalautoimmuneencephalomyelitis AT torbenkruse centralnervoussystemendogenoustlr7andtlr9inducedifferentimmuneresponsesandeffectsonexperimentalautoimmuneencephalomyelitis AT rezakhorooshi centralnervoussystemendogenoustlr7andtlr9inducedifferentimmuneresponsesandeffectsonexperimentalautoimmuneencephalomyelitis AT trevorowens centralnervoussystemendogenoustlr7andtlr9inducedifferentimmuneresponsesandeffectsonexperimentalautoimmuneencephalomyelitis |